Arca Biopharma | ABIO - SCHULD

Aktienkurs
41.56
Täglich Wechseln
2.65 6.81%
Monatlich
16.87%
Jährlich
236.25%
Q1 Prognose
37.74




SCHULD Veränderung Datum
Alterity Therapeutics Limited AUD 210.39K 120.67K 2023-06
Amgen USD 54.59B 1.62B 2025-09
Arca Biopharma USD 0 0 2025-03
Biogen USD 6.29B 1.7M 2025-12
Brainstorm Cell Therapeutics USD 1.2M 1.2M 2025-03
Bristol-Myers Squibb USD 51.04B 112M 2025-09
Capricor Therapeutics USD 3.38M 0 2025-03
Cipla INR 4.38B 231.9M 2025-03
Clal Biotechnology ILS 35.76M 28.27M 2023-12
Compugen USD 2.95M 24K 2025-09
CSL USD 11.96B 219M 2024-12
Cytokinetics USD 1.2B 338.79M 2025-09
Daiichi Sankyo JPY 201.14B 99.81B 2025-09
Gilead Sciences USD 24.94B 5M 2025-09
GlaxoSmithKline GBP 17.75B 396M 2025-09
Grifols EUR 9.23B 626.05M 2024-12
Laboratory Of America USD 6.53B 16.1M 2025-09
Myriad Genetics USD 59.3M 19.7M 2025-03
Otsuka Holdings JPY 211.51B 41.2B 2025-06
Pfizer USD 60.85B 78M 2025-09
United Therapeutics USD 200M 100M 2025-03